Patents Assigned to EpitoGenesis, Inc.
  • Publication number: 20240082381
    Abstract: The present invention provides adjuvant compositions that are capable of modulating the immune response in a subject, including enhancing or suppressing the immune response. These adjuvant compositions may also be used to enhance or suppress the immunogenicity of antigens by enhancing or suppressing antigen-presentation activity, enhancing or suppressing innate immune responses through activation or suppression of, e.g., natural killer cells, and/or direct activation of subsets of B and/or T cells. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions. In certain embodiments, the compositions comprise combinations of the following: a pharmaceutically acceptable carrier, a flavonoid, a tannin and a vitamin.
    Type: Application
    Filed: April 3, 2023
    Publication date: March 14, 2024
    Applicant: EpitoGenesis, Inc.
    Inventors: Michael Vajdy, Shohre Golestani
  • Publication number: 20240050399
    Abstract: The present invention provides flavonoid compositions that are capable of inhibiting pathogenic growth. Also provided are methods of making the compositions as well as methods of using the compositions.
    Type: Application
    Filed: October 27, 2023
    Publication date: February 15, 2024
    Applicant: EpitoGenesis, Inc.
    Inventor: Shohre Golestani
  • Publication number: 20210346340
    Abstract: The present invention provides flavonoid compositions that are capable of inhibiting pathogenic growth. Also provided are methods of making the compositions as well as methods of using the compositions.
    Type: Application
    Filed: May 7, 2021
    Publication date: November 11, 2021
    Applicant: EpitoGenesis, Inc.
    Inventor: Shohre Golestani
  • Patent number: 10765735
    Abstract: This disclosure provides adjuvant compositions that are capable of modulating the immune response in a subject. These adjuvant compositions may also be used enhance the immunogenicity of antigens. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: September 8, 2020
    Assignee: EpitoGenesis, Inc.
    Inventors: Michael Vajdy, Shohre Golestani
  • Patent number: 10561720
    Abstract: The present invention provides adjuvant compositions that are capable of modulating the immune response in a subject, including enhancing or suppressing the immune response. These adjuvant compositions may also be used to enhance or suppress the immunogenicity of antigens by enhancing or suppressing antigen-presentation activity, enhancing or suppressing innate immune responses through activation or suppression of, e.g., natural killer cells, and/or direct activation of subsets of B and/or T cells. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions. In certain embodiments, the compositions comprise combinations of the following: a pharmaceutically acceptable carrier, a flavonoid, a tannin and a vitamin. The compositions may further comprise an antigen.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: February 18, 2020
    Assignee: EpitoGenesis, Inc.
    Inventors: Michael Vajdy, Shore Padrah
  • Publication number: 20150335737
    Abstract: This disclosure provides adjuvant compositions that are capable of modulating the immune response in a subject. These adjuvant compositions may also be used enhance the immunogenicity of antigens. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions.
    Type: Application
    Filed: July 30, 2015
    Publication date: November 26, 2015
    Applicant: EPITOGENESIS, INC.
    Inventors: Michael Vajdy, Shore Padrah
  • Patent number: 9180184
    Abstract: This disclosure provides adjuvant compositions that are capable of modulating the immune response in a subject. These adjuvant compositions may also be used enhance the immunogenicity of antigens. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: November 10, 2015
    Assignee: EpitoGenesis, Inc.
    Inventors: Michael Vajdy, Shore Padrah
  • Publication number: 20130189288
    Abstract: This disclosure provides adjuvant compositions that are capable of modulating the immune response in a subject. These adjuvant compositions may also be used enhance the immunogenicity of antigens. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions.
    Type: Application
    Filed: March 7, 2013
    Publication date: July 25, 2013
    Applicant: EPITOGENESIS, INC.
    Inventor: EPITOGENESIS, INC.
  • Patent number: 8425922
    Abstract: This disclosure provides adjuvant compositions that are capable of modulating the immune response in a subject. These adjuvant compositions may also be used enhance the immunogenicity of antigens. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions.
    Type: Grant
    Filed: January 4, 2010
    Date of Patent: April 23, 2013
    Assignee: EpitoGenesis, Inc.
    Inventors: Michael Vajdy, Shore Padrah
  • Publication number: 20130028961
    Abstract: The present invention provides adjuvant compositions that are capable of modulating the immune response in a subject, including enhancing or suppressing the immune response. These adjuvant compositions may also be used to enhance or suppress the immunogenicity of antigens by enhancing or suppressing antigen-presentation activity, enhancing or suppressing innate immune responses through activation or suppression of, e.g., natural killer cells, and/or direct activation of subsets of B and/or T cells. Also provided are methods of making the adjuvant compositions as well as methods of using the adjuvant compositions. In certain embodiments, the compositions comprise combinations of the following: a pharmaceutically acceptable carrier, a flavonoid, a tannin and a vitamin. The compositions may further comprise an antigen.
    Type: Application
    Filed: June 22, 2012
    Publication date: January 31, 2013
    Applicant: EpitoGenesis, Inc.
    Inventors: Michael Vajdy, Shore Padrah